ClinicalTrials.govpublic full text
A Study to Assess Adverse Events and Disease Activity With Cedirogant (ABBV-157) in Adult Participants With Moderate to Severe Psoriasis
psoriasis, plaque psoriasis, cedirogant, abbv-157, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 1047193
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.